Company Information

CIN
Status
Date of Incorporation
20 August 2021
State / ROC
Tamil Nadu / ROC Chennai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
200,000
Authorised Capital
1,000,000

Directors

Muralidhar Prasanna
Muralidhar Prasanna
Director/Designated Partner
over 2 years ago
Rajaram Rajakumar
Rajaram Rajakumar
Director/Designated Partner
about 4 years ago
Bose Premnivas
Bose Premnivas
Director/Designated Partner
about 4 years ago
Paramasivam Anand
Paramasivam Anand
Director/Designated Partner
over 4 years ago

Registered Trademarks

Galencef S Forte Galengen Lifesciences

[Class : 5] Pharmaceutical Products.

Galengen Galengen Lifesciences

[Class : 5] Pharmaceutical Products.

Documents

List of Directors;-31102022
List of share holders, debenture holders;-31102022
Optional Attachment-(1)-31102022
Optional Attachment-(2)-31102022
Form MGT-7A-31102022
Optional Attachment-(1)-30102022
Form DIR-12-30102022
Form AOC-4-29102022
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29102022
Directors report as per section 134(3)-29102022
Optional Attachment-(1)-29102022
Optional Attachment-(3)-29102022
Optional Attachment-(2)-29102022
Form ADT-1-12102022_signed
Copy of written consent given by auditor-12102022
Copy of the intimation sent by company-12102022
Copy of resolution passed by the company-12102022
-12102022
Form DPT-3-29062022
Declaration of the appointee director, Managing director, in Form No. DIR-2;-06112021
Form DIR-12-06112021_signed
Optional Attachment-(1)-06112021
Optional Attachment-(2)-06112021
Form INC-20A-05102021_signed
-05102021
CERTIFICATE OF INCORPORATION-20210820
Form SPICe AOA (INC-34)-16082021
Form SPICe MOA (INC-33)-16082021